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The Influence of Patient and Doctor Gender on 
Diagnosing Coronary Heart Disease 
 
Abstract 
Using novel methods, this paper explores sources of uncertainty and gender 
bias in primary care doctors’ diagnostic decision making about coronary heart disease 
(CHD). Claims about gendered consultation styles and quality of care are re-
examined, along with the adequacy of CHD models for women.  
 
 Randomly selected doctors in the UK and the US (n=112, 56 per country, 
stratified by gender) were shown standardised videotaped vignettes of actors 
portraying patients with CHD. ‘Patients’ age, gender, ethnicity and social class were 
varied systematically. During interviews, doctors gave free-recall accounts of their 
decision making, which were analysed to determine patient and doctor gender effects.   
 
 We found differences in male and female doctors’ responses to different types 
of patient information.  Female doctors recall more patient cues overall, particularly 
about history presentation, and particularly amongst women. Male doctors appear less 
affected by patient gender but both male and especially female doctors take more 
account of male patients’ age and consider more age-related disease possibilities for 
men than women. Findings highlight the need for better integration of knowledge 
about female presentations within accepted CHD risk models, and do not support the 
contention that women receive better quality care from female doctors. 
 
(195 words) 
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Introduction 
Improving the early detection and management of coronary heart disease 
(CHD) remains a key health improvement target across the developed world (e.g UK 
Department of Health (DH) 2005; US National Center for Chronic Disease Prevention 
and Health Promotion (NCCD) 2005). While evidence suggests that health promotion 
and screening strategies are having a positive effect (DH 2005, NCCD 2005), the 
decline in CHD has been greater for men than women (Peltonen et al. 2000). Twice as 
many women as men aged 45-64 have undetected or ‘silent’ myocardial infarctions, 
suggesting later diagnosis (McKinlay 1996, Mikhail 2005); and women also have a 
poorer post-infarction prognosis than men, even after adjusting for clinical covariates 
(NCCD 2005, Mikhail 2005). To understand why these gender differences persist, it is 
important to focus attention on primary care where CHD is first diagnosed.  The need 
for research investigating the dynamics of the initial CHD diagnostic process amongst 
women is recognised as particularly urgent (Raine 2001, Richards et al. 2000, Mikhail 
2005).  
 
One explanation for persistent gender differences in the diagnosis, treatment 
and management of CHD is that knowledge about female presentations is not yet 
sufficiently integrated into received medical wisdom about what is ‘normal’ in CHD 
(Lorber 2000). Further, Lorber in the US contends that women receive better quality 
care for CHD at the hands of female compared with male doctors. This is based upon 
evidence about different consultation styles used by male and female doctors, which 
have also been identified by others (e.g. Roter, Lipkin & Korsgaard 1991; Hall et al. 
1994). This paper re-examines these claims using a novel analytic approach which 
combines sociological and psychological perspectives.  Much previous research has 
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focused on how patient and doctor characteristics affect outcomes of clinical decision-
making. Arber et al (2006) identified significant gender differences in doctors’ 
treatment and management decisions for patients presenting with symptoms of CHD, 
finding that doctors had greater diagnostic certainty in relation to male compared with 
female patients. In this paper we elucidate these findings by an analysis of 
complementary, qualitative data to determine how patient and doctor gender affects 
doctors’ cognitive processes during consultations, to shed light on gendered sources 
of diagnostic uncertainty and bias.  
 
We have argued elsewhere that different theories of decision-making and 
approaches to decision analysis can usefully be encapsulated within a psychological 
model of classification (Buckingham & Adams 2000a, 2000b). This psychological 
model (described below) is used to analyse primary care doctors’ accounts of decision 
making about older and middle aged patients presenting with symptoms of CHD. It 
enables us to focus on the micro-processes of doctors’ clinical decision making, and 
explore the effects of patient and doctor gender on them.  
 
First, we review relevant literature on gender and heart disease. The concept of 
clinical decision making as classification is then introduced, followed by a description 
of our analytic model and study methods. A number of hypotheses are derived and 
presented for empirical testing. Findings are discussed in the context of identifying 
sources of clinical uncertainty and potential gender bias, and in the light of Lorber’s 
(2000) claims about the better treatment of women by female doctors than male 
doctors.  
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Patient gender and heart disease  
Coronary heart disease is the most common cause of death for women both in 
the UK and the US (DH 2005, NCCD 2005), killing ten times more women than 
breast cancer (NHS Confederation Press Summaries 6 September 2005). However, it 
was only in the mid-nineties that it was recognised by the medical profession as an 
‘equal opportunity killer’ (Wenger 1994), or indeed, as is now suggested, more deadly 
for women than for men in Europe (NHS Confederation Press Summaries 6 
September 2005). Consequently, numerous studies have set out to determine gender 
effects on the diagnosis, treatment and outcomes associated with CHD, and 
researchers have found a systematic gender bias in secondary care.  In the US and UK 
women were less likely to be admitted to cardiac units, even though they were 
generally in a worse condition on admission than men (Clarke et al. 1994), and less 
likely to be re-vascularised (DeWilde et al. 2003). Similar patterns were found in 
Australia (Sayer & Britt 1996), Ireland (Bennett, Williams & Feely 2002), Sweden 
(Agvall & Dahlstrom 2001), and Austria (Hochleitner 2000).  
 
Less is known about the influence of gender in primary care however, where 
CHD is first diagnosed. Lorber’s (2000) contention about knowledge of female 
presentations being not yet sufficiently integrated into received medical wisdom about 
what is ‘normal’ in CHD may be particularly influential here. Generalist primary care 
doctors are less likely to be aware of subtle gender differences in presentation than 
cardiac specialists. This is borne out by evidence that women are less likely than men 
to receive a diagnosis of CHD in primary care (Wenger 1994, Richards et al. 2000) 
because doctors are less certain about the accuracy of this diagnosis in women, 
particularly mid-life women (Arber et al. 2006). As a consequence, women may not 
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be so thoroughly investigated. They are less likely to have CHD risk factors recorded, 
or to receive secondary prophylaxis; and if they do receive lipid lowering drugs, they 
are treated less ‘aggressively’ than men (Hippisley-Cox et al. 2001, Corbelli et al. 
2003, Mikhail 2005). This, in turn, leads to difficulty in referral for appropriate tests 
(see for example Richards et al. 2000, Bennett, Williams & Feely 2002, Arber et al. 
2006). In particular, women are less likely to be referred for echocardiography 
(Agvall & Dahlstrom 2001), or evaluation of left ventricular function (Burstein et al. 
2003). When they are referred, women may be further disadvantaged because the 
exercise ECG, the most reliable diagnostic tool for CHD, functions better in relation 
to detecting CHD in men rather than in women (McKinlay 1996, Wong et al. 2001).  
 
Prevalent stereotypical conceptualisations of CHD as a male disease also 
remain important, particularly amongst women themselves (Guilleman 2004, Ruston 
& Clayton 2002). People generally recall heart disease as being a sudden, dramatic 
collapse in male relatives, but a slow decline associated with normal ageing in female 
relatives, with stereotypical male presentations being more readily remembered 
(Emslie, Hunt & Watt 2001).  The observations made by Martin, Gordon & 
Lounsbury (1998) and Lockyer & Bury (2002), that women are more in danger than 
men of having their symptoms of CHD interpreted as being of psychosomatic origin, 
is another indicator  of a lack of integration of  knowledge about women within 
prevalent conceptualisations of what is normal in CHD.  
 
Explanations for differences in doctors’ decision-making behaviour vary. 
Lorber’s argument (2000) is in part predicated on the fact that there is an andro-
centric gender bias that runs throughout much of medical knowledge and practice 
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(Healy 1991, Hayes & Prior 2003), which pays insufficient attention to the 
distinctiveness of disease presentation amongst women. For example, women are 
under-represented in CHD-related medical trials (Rosser 1994, Mikhail 2005); at best 
they receive a ‘gender-neutral’ assessment of their symptoms, but care based on the 
needs of male patients, which could significantly disadvantage them (Borzak & 
Weaver 2000, Bandyopadhyay, Bayer & O’Mahony 2001, White & Lockyer 2001).  
 
Indeed, there is growing evidence that women often have different clinical 
presentations of CHD compared with men (e.g. Philpott et al. 2001, Mikhail 2005), 
which has led others to dispute that an inappropriate gender bias exists (Roeters van 
Lennep 2000, Wong et al. 2001). For example, women being treated less aggressively 
than men could rightly reflect real clinical differences in women’s CHD profile, 
where their target lipid levels are different from men’s (Wild 2001). Others contend 
that there is a gender bias in the opposite direction, arguing that men are generally 
over-treated (Kitler 1994). Unravelling the extent to which inappropriate, 
stereotypically-gendered thinking affects the diagnosis, treatment and management of 
CHD is highly important, yet complex to execute. Our study methods (described 
below) explain how we have sought to understand how this affects diagnosis, by 
controlling for clinical presentation, social interaction and behavioural differences 
within consultations.  
 
Gender differences in the treatment of CHD are also confounded by the 
influence of other variables, such as age, socio-economic status (SES) (Lawlor, 
Ebrahim & Davey Smith 2002a, 2002b) and ethnicity (Schulman et al. 1999). Our 
own work (Arber et al. 2004, 2006), has highlighted the importance of age and gender 
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interaction, suggesting significant under-investigation of CHD in middle-aged women 
in particular. In this paper we examine gender differences amongst mid-life and older 
patients, while simultaneously controlling for the effects of ethnicity and social class, 
and compare how doctors locate male and female patients’ symptoms according to 
age-related disease expectations.   
 
The influence of doctors’ gender 
 An apparent lack of awareness of CHD in women amongst many health care 
professionals has recently been noted as a worrying phenomenon (Mikhail 2005), and 
is important to examine in terms of doctors’ gender. While there is considerable 
evidence about the impact of patients’ gender on the treatment and management of 
CHD (demonstrated above), much less is known about the impact of doctors’ gender, 
and particularly about how it affects diagnostic decision-making in primary care.  
 
Available literature about the effects of doctor gender tends to focus on 
differences in consultation styles and interaction patterns between male and female 
doctors with their patients. Women doctors encourage patients to talk more and 
develop fuller history narratives, to be involved in decision making, demonstrate more 
supportive non-verbal communication, conduct longer consultations and are more 
likely to perform female prevention procedures (Lorber & Moore 2002, Lorber 2000, 
Roter, Lipkin & Korsgaard 1991, Hall et al. 1994).  Based on her examination of 
existing research evidence, Lorber (2000) contends that “women patients…do not get 
the best treatment for heart disease nor do they get good preventive care….unless they 
have a woman doctor” (p.45). Women use primary care services more than men 
(Hayes & Prior 2003), and with more women choosing to see female doctors (Franks 
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& Bertakis 2003), and a steady growth in the numbers of women entering primary 
care medicine, it is timely to re-examine this claim.  
 
In summary, we aim to investigate the influence of both doctors’ and patients’ 
gender on doctors’ cognitive processes during clinical decision-making, to identify 
sources of uncertainty in the diagnosis of CHD. We are particularly concerned with 
unravelling the extent to which inappropriate, stereotypically-gendered thinking gives 
rise to inequity in the early stages of women’s care, and how this is influenced by 
patients’ age. The next section describes our approach to investigating these cognitive 
processes for clinical decision making.  
 
Clinical decision making as classification 
 
Insert Figure 1 about here 
 
Building on earlier work (Buckingham & Adams 2000a, 2000b), we have 
developed a detailed psychological model of clinical decision making within 
consultations, which interprets it as three linked, iterative classification tasks 
(diagnosing, assessing potential outcomes and making intervention decisions – see 
Figure 1). In this paper we focus on the first task of diagnostic decision making only, 
since the literature review suggests that this is the stage requiring most urgent 
investigation (Raine 2001, Richards et al. 2000, Mikhail 2005).  
 
When making a diagnosis, the ‘raw materials’ doctors’ work with is a set of 
patient attributes and those pertaining to the health-care context (e.g. health setting, 
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cost of interventions, availability of tests).  Referring to Figure 1, doctors select from 
this material what they believe to be relevant patient cues (e.g. gender but not eye 
colour from the whole set of patient attributes), and contextual information for making 
a diagnosis. The relevant cues then enter the psychological classification process, 
having been given a psychological interpretation if appropriate (e.g. a specific age 
might be interpreted as “elderly”). The different cues are then integrated to determine 
their combined influence on differential diagnostic classes. Each class is paired with 
the certainty that the doctor believes the patient belongs to it. The classification 
process is iterative, with cues bringing to mind particular diagnostic classes, which 
then suggest further cues to be sought, and so on.  
 
By deconstructing the diagnostic processes into constituent parts, a mechanism 
is provided for revealing the different psychological components of clinical decision 
making, the potential influences on them, and how they affect resulting diagnostic 
decisions. It suggests a number of areas where decision making may be prone to 
gender bias: the number and nature of cues influencing classification; the knowledge 
structures used by doctors (explained later); and how doctors process cues and 
knowledge structures to estimate the certainty that the patient has a particular 
diagnosis. We refer to each of these areas where variation may occur as a decision-
making component. The classification model is used to derive hypotheses about the 
different components that can be tested for gender-related bias, which will be 
explained below after we describe the study methods that generated the required data.  
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Study methods 
The qualitative data about primary care doctors' decision making analysed in 
this paper were collected within the context of a large cross-national study with a 
factorial experimental design (Cochran & Cox 1957), permitting control for the 
effects of doctor, patient and health service characteristics. The study was conducted 
simultaneously in the United States (Massachusetts) and the United Kingdom 
(Surrey/South West London and the West Midlands) in 2001-2002, to estimate the un-
confounded effects of patient characteristics on different types of decisions made by 
primary care doctors. These included diagnostic, test ordering, treatment and referral 
decisions, when presented with patients manifesting symptoms strongly suggestive of 
CHD or depression. In this paper, we focus only on decision making related to CHD. 
A full factorial of 24 = 16 combinations of patient age (55 versus 75), gender, race 
(white versus black: African American in the US or Afro-Caribbean in the UK) and 
SES (lower versus higher social class – a cleaner / janitor versus a teacher) was used 
for the video scenarios.  One of the 16 combinations was shown to each physician for 
each medical problem (2 videos per physician structured such that half saw the CHD 
vignette last).  Eight strata of physician (gender, years of clinical experience [<12 or 
>22 years]) and country (US/UK) characteristics were defined, to generate a total of 
16 x 2 x 8 = 256 physicians required to complete the experimental design. 
 
Insert Table 1 about here 
 
Professional actors were used to create realistic videotaped portrayals of 
primary care consultations, which incorporated key symptoms for CHD.  Such 
methods have been used successfully by the team in previous research examining 
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primary care decision-making (McKinlay et al.1997, 2002, McKinlay, Potter & 
Feldman 1996), and by others (e.g. McKinstry 2000). Scenarios were taped 
repeatedly, systematically varying the ‘patient's’ age, race, gender, SES and accent 
(UK v. US, Table 1).  
 
Insert Table 2 about here 
 
Measures were taken to ensure the ecological and external validity of the 
scenarios for both countries, and to ensure identical clinical information portrayal by 
each ‘patient’.  For example, doctors were shown scenarios in their surgeries during 
normal working hours, were instructed to view video patients as one of their own, and 
to ground subsequent care decisions within existing local constraints (doctors were 
also asked at interview how typical scenarios were, and 92% said either ‘reasonably’ 
or ‘very’ typical).  The videos were shown to 256 primary care doctors, stratified by 
country (US v.UK), gender, and years of clinical experience (see Table 2). US doctors 
were randomly sampled from the Massachusetts Medical Society list and UK doctors 
from Surrey/South West London and West Midlands Health Authority lists. The 
sample of 256 doctors represents response rates of 65% and 60% of eligible doctors 
initially approached in the US and UK respectively.  
 
After viewing each video scenario, doctors were asked about diagnosis and 
treatment decisions.  Then, after viewing both scenarios, they were invited to give a 
free recall, unprompted account of their decision making processes about the video 
scenario they saw last (half or 128 physicians saw the CHD scenario last).  The 
doctors’ instructions were: “I would like you to think back to the beginning of the 
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second consultation and to describe your thoughts as they occurred during it.  I am 
particularly interested in when a possible diagnosis first entered your mind and how 
the diagnoses developed on the way to your final conclusions. Starting at the 
beginning then, can you replay the tape in your mind and tell me what your thoughts 
were about the patient?” 
 
This approach allows doctors to articulate thoughts based on their 
chronological genesis, thereby providing information not usually available about 
what, in their minds, was most significant about the video presentations, and about 
how their thoughts developed on the way to reaching their conclusions about 
diagnoses. Analysis of these data, referred to as the 'cognitive' data, is the focus of this 
paper. This free recall opportunity was followed by semi-structured questions 
designed to elicit information about uncertainty representation and doctors’ 
knowledge structures. Due to missing and incomplete data, 112 (out of 128) accounts 
were analysed. These were provided by 56 doctors in each country, elicited in 
response to equal numbers (n = 56) of male and female patient presentations, thus 
constituting a balanced dataset according to the variables of interest.  
 
Cognitive data were tape-recorded and transcribed verbatim by project support 
staff in both countries. Analysis was undertaken by one researcher (AA) in the UK, 
comprising thematic analysis using QSR NVivo 1.4 software, reflecting the 
components of the classification model of clinical decision making.  This involved an 
iterative process of developing a coding framework that embraced not only all of the 
important theoretical decision-making components, but also ensuring sufficient 
flexibility to identify additional concepts arising from the data. (See appendix for a 
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list of codes and examples). Inter-rater reliability of coding (undertaken by AA and 
CDB) reached 90% agreement when applied to the free recall data.  
 
The next section describes how we investigated gender-related bias and the 
results. It provides more specific detail about the codes used and how they were 
applied to the data, with analysis of variance used to test all relationships in the data.  
The study design consisted of seven factors: four patient factors (gender, age, race, 
SES), two physician factors (gender, level of experience), and country.  The analysis 
of variance model focussed on gender main effects and interactions. In the absence of 
missing data, all effects would be orthogonal but due to missing 16 out of 128 
responses, Type III sums of squares were used. All analyses were conducted using 
SAS version 9.1.   Least square means (adjusting for the other variables in the model) 
and associated 95% confidence intervals are given in Tables 3 and 4.  Two-tailed tests 
were used because the mechanisms by which micro-cognitive processes are affected 
by gender are unknown, and because differences in either direction are of interest. 
 
Testing for gender bias 
The 3 components of our classification model of clinical decision making that 
relate to diagnosis will be investigated with respect to gender effects. Each comprises 
one or more micro-processes that will be analysed in turn to identify any influences of 
doctor and patient gender. Interaction effects will also be considered, but only the 
significant ones will be reported due to the number of potential interactions.  Each 
micro-process is described, and outcomes associated with potential gender bias 
considered. Results of the analysis are presented in Tables 3 and 4. Table 3 shows 
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independent influences of patient and doctor gender, and Table 4 shows significant 
interaction effects.  
 
[Put Tables 3 and 4 about here] 
 
Component 1: the number of unique cues considered by doctors 
 Every mention of a patient cue was coded and the distinct cues counted 
because the number of clinical, biographical, social or psychological pieces of data 
has implications for the number and range of diagnostic hypotheses entertained by 
doctors. Consideration of fewer patient cues may lead to fewer and less well-
developed diagnostic hypotheses, with the potential to miss important ones (e.g. 
CHD).  If there are systematic differences in the number considered for either male or 
female patients, this indicates less attention to their case and the potential for doctors 
to miss significant influences affecting diagnoses and subsequent care. However, the 
mean number of cues recalled for male and female patients was 11.02 and 12.02 
respectively, which was not significantly different.  
 
We went on to examine differences between the numbers of unique cues 
recalled by female doctors compared with male doctors, and found the mean number 
of cues recalled to be 12.6 and 10.6 respectively. This is a statistically significant 
difference (p=0.037), occurring in the absence of any systematic differences in the 
lengths of male and female doctors’ free recall accounts. It indicates that female 
doctors may be more open to a wider set of potentially influential factors than male 
doctors.  
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These differences could be associated with the direction of reasoning, where 
forward or data-driven reasoning gathers cues and uses them to suggest a range of 
diagnoses, whereas goal-driven or backward reasoning tries to find data associated 
with a particular diagnosis. Consultations always iterate between the two directions, 
but to varying degrees. If backward reasoning predominates, there may not be enough 
cues gathered to generate a full set of differential diagnoses and focussing on the most 
likely ones will tend to generate a smaller set of confirming cues rather than ones 
suggesting alternative diagnoses. It may even lead to confirmation bias (Klayman 
1995), when people try to prove the truth of ideas instead of disproving them. If it was 
taking place in this study, male doctors should have greater certainty of CHD than 
female doctors, but quantitative data collected from 256 doctors as part of the wider 
study did not show a significant difference. It is possible, though, that the type of cue 
is more influential than the numbers, which we explore next. 
 
Systematic differences in the type of cues considered for either male or female 
patients may indicate over-sensitivity to some types of information and blindness to 
others. To test for it, cues recalled by doctors were coded into psychological, social, 
presentation, and medical history categories, described below.  
 
Psychological cues relate to doctors’ comments about a patient’s state of mind 
(see appendix). The overall mean number recalled was 1.4, with 1.7 considered for 
women and 1.1 for men, which is a statistically significant difference (p=0.036, Table 
3, row b). These findings support previous research (e.g. Emslie, Hunt & Watt 2001, 
Martin, Gordon & Lounsbury 1998, Lockyer & Bury 2002) by indicating that doctors 
are more likely to tune into psychological cues and to search for psychological 
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explanations for women’s symptoms than they are for men.  There was no significant 
difference between doctor gender for these cues, though, which means both male and 
female doctors are equally prone to the behaviour.  
 
Presentation cues concern the manner in which patients present their history 
and symptoms (see appendix). Female doctors were found to recall significantly more 
presentation cues compared to their male counterparts (mean scores of 1.33 compared 
with 0.90 respectively, p=0.040, Table 3, row c).  A significant interaction between 
patient gender and doctor gender (p=0.014) shows that the main cause of the 
difference between male and female doctors is due to how female doctors interact 
with female patients (Table 4, row a). Women doctors recall more presentation cues 
for female than male patients (mean cues of 1.72 compared with 0.94), whereas the 
difference for male doctors is less marked, albeit in the opposite direction, favouring 
men (mean cues of 0.75 and 1.03 for female and male patients respectively). These 
findings suggest that doctors are more attuned to the way in which patients of their 
own sex present their history, and that this is enhanced in the case of women doctors 
consulting with female patients, as Lorber & Moore (2002) suggest.  
 
Patient medical history cues relate to pieces of information about past or 
present diseases, illnesses, and medical events affecting either the patient or their 
family, which may influence patients’ current or future health (see appendix). No 
significant effects of patient or doctor gender were found on the number of medical 
history cues recalled.  
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Our previous work showed interesting effects of patient age on diagnostic 
behaviour (Adams et al. 2006), but without specifically identifying how it influences 
decision making about male and female patients. To find out whether age is noted 
more for women or for men, its influence on decision making was recorded as a 
binary value, ‘yes’ if age was mentioned at all and ‘no’ otherwise. This exposed a 
significant difference between patient genders (p=0.018), with 81% of doctors 
mentioning age in relation to males but only 63% in relation to females (Table 3, row 
e).   These findings corroborate the influence of age, suggesting it is a more important 
‘anchor’ for doctors in terms of considering potential diagnoses for men than it is for 
women, and possibly underpinning Healy’s (1991) contention that most medical 
knowledge reflects a male gender bias.  
 
Examination of interactions between doctor and patient gender (Table 4, row 
b) reveals female doctors mention age more for male patients than female patients 
(91% of the time versus 50%), whereas male doctors treat them roughly the same 
(72% versus 75%, male to female). This indicates that the gender effect is really down 
to the different behaviour of female doctors, suggesting that while female patients’ 
presentation of history and symptoms resonates more with female doctors, female 
doctors are simultaneously less likely to be attuned to the clinical significance of their 
age when it comes to making diagnostic decisions.  
 
Component 2: Doctor’s diagnostic inferences 
 Figure 1 shows that the inference process for linking cues to diagnostic classes 
is an integral part of clinical decision making. Component 2 examines these 
inferences, which are any inferred attributes of the patient, such as diseases (e.g. 
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CHD) or non-medical attributes like social isolation (see appendix). Increased 
inferences indicate a more open mind to different diagnostic possibilities, and an 
increased likelihood that the correct diagnosis will be present within a doctor’s set of 
differentials. This is especially important during the early stages because Barrows et 
al. (1982) showed that only 14% of physicians will eventually identify the correct 
diagnosis if it is absent from the initial differential set.  
 
The mean number of diagnostic inferences was 4.70, showing no significant 
gender differences, either between doctors or patients (Table 3, row f). However, it 
was seen above that gender differences were found with respect to mentioning the age 
cue (Table 3, row e), so it is pertinent to explore whether age is also having an impact 
on gender with respect to diagnoses, by examining age-related inferences. An 
example is a doctor saying a patient is just the right age and type of person to have 
CHD. In this analysis, age has to be explicitly associated with an inference, testifying 
to its specific influence on decision making rather than simply being noted as a patient 
attribute (see appendix).  
 
Given that age is more often mentioned with respect to male patients (see 
above), it is not surprising to see this repeated for the association of age with 
diagnostic inferences. Male patients received an average of 1 inference associated 
with age (Table 3, row g), twice as many as the number for females (0.50, p=0.001). 
Furthermore, the difference is again mostly linked to female doctors (p=0.036, Table 
4, row c), whose number of age-related inferences is 1.22 for males and 0.41 for 
females, compared to the smaller difference of male doctors (0.78 versus 0.59, for 
male and female patients respectively). These findings underline the importance of 
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age as an influence on gender differences in diagnostic behaviour: it is mentioned 
more often by female doctors and is more influential on their diagnoses, but only with 
respect to male patients.  
 
The increased number of age-related inferences for male patients seems to be 
having a real effect on diagnostic accuracies because there was a significant 
difference according to patient gender (p=0.031) when the 256 doctors were asked for 
their certainties of CHD in the quantitative part of this study (reported by Arber et al., 
2006).  The doctors estimated their certainties of CHD to be 57% certain for men, 
compared with 47% for women, which correlates with better accuracy because the 
scenarios were supposed to indicate CHD as the correct diagnosis. 
  
Component 3: Knowledge structures used by doctors  
 The analysis of gender effects has concentrated so far on cue selection and 
their relationship to inferences for diagnostic classes. We now turn to how cues relate 
to each other within the knowledge structures doctors possess. 
 
 In terms of psychological classification, there are two fundamental models for 
representing knowledge about classes (see Hampton 1993): the prototype model, 
which represents a class by a single, most typical member; and the exemplar model, 
which represents classes by all their known members. Prototypes do not directly hold 
information about disease frequencies, whereas the exemplar model does, because it 
stores all the members, and thus incorporates class sizes. The difference is important 
because failing to take account of class sizes means that the existing evidence base for 
prior probabilities of diseases and outcomes is potentially ignored, which, in terms of 
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gender issues, would mean doctors failing to take account of the frequencies of CHD 
within male and female populations, and over-reliance on matching patients to disease 
stereotypes when making diagnoses. 
 
The second difference between prototypes and exemplars is that the exemplar 
representation holds more information on variability amongst class members by 
retaining all the different manifestations and their particular combinations in each 
member.  This may enable more unusual symptom patterns to be correctly matched to 
a doctor’s disease representation, such as women’s different descriptions of angina 
compared with men’s (Philpott et al. 2001, Mikhail 2005), and thus facilitate more 
accurate diagnoses. If women do not present with typical CHD symptoms, then they 
may be disadvantaged by doctors’ over-reliance on prototypes.  
 
Our coding scheme (see appendix) enabled us to test three important 
relationships between gender and the use of knowledge structures, namely, between 
gender and the use of prototypes; the use of exemplars; and the use of explicit 
probabilistic information (given by the disease frequency or probability code). 
Analyses failed to detect any significant gender effects, which means gender 
differences in diagnostic accuracy are not caused by the way knowledge is structured 
or how probabilistic information is integrated.  
 
Summary and conclusions 
 Through the use of novel analytic methods combining sociological and 
psychological perspectives, this paper aimed to provide new insights into sources of 
uncertainty and gender bias in primary care doctors’ diagnosis of CHD. In particular, 
 21
it re-examined three important contentions in medical sociological literature:  that 
there are differences in male and female doctors’ consulting styles; that knowledge 
about female presentations is not yet sufficiently integrated into received medical 
wisdom about what is ‘normal’ in CHD; and that women receive better quality CHD 
care from women doctors. 
 
Our findings confirm the importance highlighted by others (Raine 2001, 
Richards et al. 2000, Mikhail 2005) of investigating gender differences in the initial 
diagnostic process for CHD. However, we failed to find evidence of differences due 
to variations in the knowledge structures used by male and female doctor, indicating 
that doctors diagnoses’ were not inappropriately influenced by gender-stereotypical 
thinking, or failure to integrate probabilistic information. Instead, we found 
differences in the way male and female doctors respond to patient information, 
particularly in their perceptions of cue relevance and salience for potential diagnoses. 
Compared with their male colleagues, female doctors recall more patient cues and pay 
more attention to the way in which patients present their verbal histories, particularly 
in the case of female patients. These findings confirm differences in male and female 
doctors’ consulting styles, with female doctors being particularly interested in patient 
narratives, as described by others (e.g. Roter, Lipkin & Korsgaard 1991, Hall et al. 
1994, Lorber 2000, Lorber & Moore 2002).  
 
Paying attention to the significance of women’s age is not reflected in female 
doctors’ interest in women’s histories, though. By contrast, both male and female 
doctors, but especially females, took particular account of male patients’ age when 
diagnosing, and generated a greater number of age-related diagnostic hypotheses for 
them than for women. More focus on men’s age may, in part, reflect the historical 
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male bias in medical knowledge, arising out of women’s under-representation in 
CHD-related medical research. Our findings therefore support Lorber’s (2000) 
conclusions, that knowledge about female presentations is not yet sufficiently 
integrated into received medical wisdom about what is ‘normal’ in CHD. On the other 
hand, the greater focus on men’s age may reflect more documented concern about the 
higher rates of mortality from CHD associated with increasing age amongst men 
compared with women (Lawlor, Ebrahim & Davey Smith 2002b).   
 
However, there may be something else going on in addition to clinical 
uncertainty. It has already been noted that prevalent stereotypical conceptualisations 
of CHD as a male disease remain important amongst women (Guilleman 2004, 
Ruston & Clayton 2002), suggesting a reluctance amongst women to accept that they 
are equally prone to CHD as they get older. This reluctance may translate into female 
doctors having a higher age threshold over which they will recognise potential CHD 
amongst women compared with men. Something akin to this is described by Bernard 
(1998), who examines female nurses’ responses to caring for older women compared 
with older men. She identifies that nurses’ discomfort with caring for their own sex, 
and comparative greater ease in caring for men, is associated in part with wishing to 
remain ‘blind’ to their own ageing, and the likely ill-health and role change 
consequences associated with it. On the other hand, due to the long standing male bias 
in medical knowledge and clinical research, male doctors may be more accepting of 
the potential for CHD amongst their own sex. 
 
Whatever is the explanation for less attention being paid to the significance of 
women’s age as a risk factor for CHD, a key question remains: Do the identified 
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gender differences have clinical significance, causing biases with potentially 
detrimental clinical consequences for patients? To determine this, it is necessary to re-
consider population trends for CHD. Although new evidence about a change in trend 
is coming to light (NHS Confederation Press Summaries, 6 September 2005), to date, 
the known prevalence of, and mortality from, CHD has been higher amongst men than 
women (DH 2005, NCCD 2005). Despite standardisation of patient presentations, this 
received knowledge of population base rates may legitimately affect doctors’ 
diagnostic certainty, as discussed above. Nevertheless, the patient presentations in our 
video-taped vignettes contained a high number of cardinal symptoms, universally 
recognised as being strongly suggestive of CHD. This means that doctors’ certainty 
about a CHD diagnosis should have been high, irrespective of patient gender, raising 
some concern about the significant difference found between male and female 
patients in the quantitative part of this study (57% versus 47%, Arber et al. 
2006). This was the case for doctors of both genders, casting doubt on Lorber’s 
(2000) contention, that women receive better CHD care from female doctors. 
Indeed, our study makes this seem more unlikely given that female doctors pay 
significantly less attention to patients’ age for women than men, when male 
doctors showed no difference. This has significant implications because: women 
are greater consumers of primary health care than men; numbers of female doctors are 
increasing in the primary care workforce; and female patients are more likely to 
choose to be seen by them (Franks & Bertakis 2003). It highlights the need for better 
developed risk and diagnostic models of CHD for women, particularly with respect to 
the influence of age, which was the main source of gender differences between 
patients. 
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 Compared to female doctors, males work with fewer patient cues and appear 
to be less influenced by patients’ gender when making diagnostic decisions. Results 
for them demonstrate more similarity in their dealing with information about male and 
female patients, except where both male and female doctors demonstrate gender bias, 
in relation to recalling more psychological cues about female patients. However, it 
may be that the observed gender neutrality of male doctors in diagnostic decision-
making disadvantages men, if there are good clinical reasons for treating them 
differently to women, as suggested by others (e.g. Roeters van Lennop 2000, Wong et 
al. 2001).  
 
The validity of our results resides in the rigour of our research methods. These 
involved a meticulously designed factorial experiment, generation of stratified 
random samples of primary care doctors in each research locality, and the use of 
ecologically valid video vignettes of simulated patients as stimuli for data collection.  
Doctors’ unstructured ruminations on their thoughts about patients were then analysed 
according to the component parts of our classification model of diagnostic decision 
making, through the rigorous application of the associated coding scheme we have 
developed. We are thus confident that our findings can be generalised.  
 
A limitation of the study is the timing of the collection of the ‘cognitive data’, 
which followed structured questions about the scenarios. In order to capture doctors’ 
dynamic reasoning processes, data should ideally be collected both during, and 
immediately after, watching video-taped scenarios, thus providing no opportunity for 
post-hoc justification (Ericsson & Simon 1993).  This was not possible in the current 
study, but we will do this in future work, and compare the results. Another limitation 
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relates to the use of standardised video-taped scenarios for controlling for variation in 
patient presentation. These inevitably remove naturally occurring variation in the 
ways in which men and women present during consultations, which may have 
influenced doctors’ decision-making. Furthermore, the use of videos prevents 
interaction of the doctors with the patients, thereby removing any impact of their 
particular consultation styles. However, without standardising presentations and 
controlling for confounding variables, we should not have been able to present our 
results with confidence: no solution is perfect.    
  
In summary, there may be doubt about whether differences between male and 
female patients’ CHD diagnoses are based on reliable clinical evidence, but there 
should not be variations in the process of clinical decision making simply due to the 
doctor’s gender. Patients are entitled to expect the same quality of care whichever 
gender attends to them, but our research has demonstrated that this may not 
necessarily be the case. More research is needed into the causes of these doctor gender 
differences and how they can be counteracted to ensure equality of care, in addition to 
investigating disparities in CHD diagnoses between men and women. 
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Appendix: Coding Scheme and Examples of Codes 
NB: examples of coded text are underlined 
 I Patient Cues are any descriptive attributes of the patient, (including their age or 
gender); any symptoms offered by the patient; or any direct observations of a patient’s 
behaviour by the doctor e.g: 
she was rather thin
he reported frequent headaches
she seemed very debilitated. 
 
Psychological Cues are a subset of patient cues, where the above attributes, 
symptoms and observations are of psychological origin e.g: 
  He seemed very low
  She said she felt very depressed. 
 
Presentation cues are also a subset of patient cues, representing doctors’ 
observations about the manner in which patients present their history, e.g: 
  he doesn’t give a very cogent history 
  She’s a passive victim, something about the tone that suggested that 
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Medical history cues are also a subset of patient cues, and relate to pieces of 
information about past or present diseases, illness and medical events affecting 
either the patient or their family, which may influence patients’ current or 
future health e.g: 
  He has been a diabetic for 2 years
  She suffered from depression in the past
  His father died of a heart attack at age 50. 
 
II Doctors’ Inferences are any inferred attributes of the patient, which may be 
potential diseases or patient attributes that are being inferred from lower-level data 
e.g. 
I think he is suffering from coronary heart disease
he has no family or friends and no regular social activities which makes me think he is 
socially isolated. 
 
Age-related inferences are a subset of doctors’ inferences, where a doctor 
says a patient is just the right age and type of person to have a certain 
condition. Age has to be explicitly associated with an inference, testifying to 
its specific influence on decision making rather than simply being noted as a 
patient attribute, e.g: 
  At 45 she is in the right age group for a gall bladder problem 
 36
  at his age, cancer has to be considered
 
III Disease frequency or probability statements relate to doctors’ statements about 
the likelihood and how often a disease may be present within certain groups of people 
e.g: 
there is a higher than average incidence of coronary heart disease in elderly black 
males 
type 2 diabetes is more likely in people over 50. 
 
IV Disease knowledge (prototypical information) is applied to statements that go 
beyond just the normal association of patient cues with inferences. The code is 
applied to any statement providing additional information about causal, probabilistic, 
or other more complex relationships existing between cues and inferences, which are 
clearly related to those inferences in general, not just how they apply to the particular 
patient in the consultation. This is akin to a classic textbook description of a disease 
e.g:  
She had all the features of typical angina
insomnia, loss of appetite, early morning waking and general lack of interest in life 
are all common manifestations of depression. 
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V Knowledge from previous patients (exemplar information) is applied to statements 
where doctors specifically refer to previous patients they have seen or where the 
information they are using comes from their experience of treating previous patients 
e.g: 
I have been caught out in the past by missing stomach cancer 
A patient I saw last week had exactly these same symptoms of headache and rash. 
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Patient attributes (eg
gender, eye colour) and 
health-care context (eg
availability of tests)
Cue 
integration
and 
inference
process
Psychological
representation
of cues 
(eg middle-aged)
relevant cues (eg
age, gender)
Cue 
selection
Patient 
management
Potential 
patient
classes (eg
diagnoses, 
outcomes,
interventions)
Certainties that
patient belongs 
to class
Figure 1: Psychological model of clinical decision making (CDM) based on 
classification. The same process applies to all three CDM tasks: classification of 
diagnoses, potential outcomes, and interventions. The arrow from the classes and 
certainties leading back to the cue selection process illustrates the cyclical nature 
of CDM: the outputs of each stage can be input to the next stage, with iteration 
of stages as required. 
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Table 1: Combination of Patient Characteristics in the Experiment 
     
Patient Characteristics 
 
                       Values  
Age 
 
55 years 
 
75 years 
 
 
Gender 
 
 
Male 
 
Female 
 
Race 
 
White 
 
Black 
(Afro-Carribbean) 
 
 
Social Class/ 
Occupation 
 
Janitor/ 
Cleaner 
 
 
School Teacher 
 
24   = 16 Videos (combinations of patient characteristics) 
 
 
Table 2: Number of Primary Care Doctors in the Experiment by 
Gender, Year Completed Medical Training and Country 
 
 
 Location  
 
Doctor 
characteristics 
 
 
Massachusetts, 
USA 
 
Surrey & South 
East London 
 
 
Midlands 
 
Total 
 
Male 
    Older (1965-1979)* 
 
 
32 
 
 
16 
 
 
16 
 
 
64 
          
    Younger (1989-1996)* 
 
 
32 
 
16 
 
16 
 
 
64 
Female 
    Older (1965-1979)* 
 
 
32 
 
 
16 
 
 
16 
 
 
64 
 
    Younger (1989-1996)* 
 
32 
 
16 
 
16 
 
64 
 
Total 
 
128 
 
64 
 
64 
 
256 
 
         
 
*   Year completed medical training 
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Table 3: Results of testing differences between patients’ and doctors’ gender. 
 
Patient Gender (mean scores) Doctor Gender (mean scores) Decision-making 
component Male Female Sig. 
level 
Male Female Sig. 
level 
Component 1: number of cues considered 
(a) Unique 
general patient 
cues of all types 
11.02 12.02 ns 10.61 
(9.28-11.94) 
b
12.61 
(11.28–13.94) 
b
p=0.037 
 
(b) Psychological 
cues 
1.09 
(0.67-1.52) 
b
1.72 
(1.32-2.11) 
b
P=0.036 1.22 1.60 ns 
(c) Presentation 
cues 
0.98 1.20 ns 0.90 
(0.60-1.90) 
b
1.33 
(1.03-1.62) 
b
p=0.040 
(d) Medical 
history cues 
0.42 0.63 ns 0.50 0.55 ns 
(e) Age cue 
mentioned for 
patients 
0.81 
(0.70-0.92) 
b
0.63 
(0.52-0.73) 
b
p=0.018 
 
0.73 0.70 ns 
Component 2: diagnostic inferences 
(f) All inferences 4.73 4.70 ns 4.81 4.63 ns 
(g) Age-related 
inferences 
1.00 
(0.79-1.21) 
b
0.50 
(0.30-0.70) 
b
P=0.001 0.69 0.81 ns 
Component 3: knowledge structures used by doctors 
(h) Use of 
prototypes 
1.38 1.86 ns 1.44 1.80 ns 
(i) Use of 
exemplars 
0.44 0.56 ns 0.55 0.45 ns 
(j)Use of 
probabilistic 
information 
0.30 0.55 ns 0.58 0.27 ns 
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Table 4: Significant Interaction Effects between Patients’ and Doctors’ Gender 
 
Doctor 
Gender 
Male  
(mean scores) 
Female 
(mean scores) 
Patient 
Gender 
Male Female Male Female 
Component 1: number of cues considered 
Significance
Level 
(a) 
Presentation 
cues 
1.03 
(0.60-1.46) 
b
0.75 
(0.34-1.16) 
b
0.94 
(0.50-1.38) 
b
1.72 
(1.32-2.11) 
b
p=0.014 
(b) Age cue 
mentioned 
for patients 
0.72 
(0.56-0.88) 
b
0.75 
(0.60-0.90) 
b
0.91 
(0.75-1.07) 
b
0.50 
(0.35-0.65) 
b
p=0.007 
Component 2: diagnostic inferences 
© Age-
related 
inferences 
0.78 
(0.48-1.08) 
b
0.59 
(0.30-0.88) 
b
1.22 
(0.91-1.52) 
b
0.41 
(0.13-0.68) 
b
p=0.036 
 
b 95% confidence intervals 
ns = p>0.05 
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